has been cited by the following article(s):
|
[1]
|
Transcription-associated cyclin-dependent kinase 12 (CDK12) as a potential target for cancer therapy
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer,
2023
DOI:10.1016/j.bbcan.2022.188842
|
|
|
|
|
[2]
|
Differentially expressed discriminative genes and significant meta-hub genes based key genes identification for hepatocellular carcinoma using statistical machine learning
Scientific Reports,
2023
DOI:10.1038/s41598-023-30851-1
|
|
|
|
|
[3]
|
Gene Expression and Metadata Based Identification of Key Genes for Hepatocellular Carcinoma Using Machine Learning and Statistical Models
IEEE/ACM Transactions on Computational Biology and Bioinformatics,
2023
DOI:10.1109/TCBB.2023.3322753
|
|
|
|
|
[4]
|
RNA Therapeutic Options to Manage Aberrant Signaling Pathways in Hepatocellular Carcinoma: Dream or Reality?
Frontiers in Oncology,
2022
DOI:10.3389/fonc.2022.891812
|
|
|
|
|
[5]
|
Targeting CDK12 for Cancer Therapy: Function, Mechanism, and Drug Discovery
Cancer Research,
2021
DOI:10.1158/0008-5472.CAN-20-2245
|
|
|
|